Aachen - Start of a new trial site

On 30 March  2026, the University Hospital Aachen became officially an active trial site of the STOP-PKD Study.

Dr. med. Susanne Fleig´s team cares for patients with a wide range of nephrological issues, including those affected by autosomal dominant polycystic kidney disease (ADPKD).

Interested patients can now make an appointment at the trial site in Aachen to obtain detailed information about the trail and potential participation.

Phone: + 49 (0) 241 80 89532

Email: sekretariatmk2@ukaachen.de